Opportunity Information: Apply for PA 08 217

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Drug Abuse Prevention Intervention Research (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Dec 5, 2008 and posted on Jul 28, 2008.
  • Applicants must submit their applications by Sep 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Private institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Special district governments Public housing authorities/Indian housing authorities.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PA 08 217

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Drug Abuse Prevention Intervention Research (R01) funding opportunity (PA-08-217) is a National Institutes of Health discretionary grant program designed to strengthen and expand the science of preventing drug abuse and drug-related HIV. It supports full-scale Research Project Grant (R01) studies that move beyond describing problems and instead generate actionable prevention knowledge. The main focus is on discovering and improving approaches that can reduce drug abuse and dependence and, at the same time, reduce downstream harms that often travel with substance use, including drug-related HIV and other infections (such as hepatitis B and hepatitis C), co-occurring mental health problems, interpersonal violence, criminal justice involvement, and losses in work or school productivity. A consistent theme across the announcement is building evidence that can realistically translate to broader, population-level impact rather than remaining limited to small, highly controlled settings.

The FOA encourages four major types of research. First, it seeks the development of novel prevention approaches, meaning new strategies, programs, or models that could prevent initiation, escalation, or harmful consequences of drug use. Second, it supports the testing of novel and adapted prevention intervention approaches, which includes both evaluating newly created interventions and rigorously examining interventions that have been modified for new populations, cultures, delivery systems, or real-world constraints. Third, it prioritizes research that explains how evidence-based interventions are selected, adopted, adapted, implemented, sustained over time, and financed. This implementation-oriented emphasis recognizes that even well-supported interventions can fail to make a difference if they are not feasible, affordable, acceptable to communities, or maintainable within schools, clinics, justice settings, social service systems, or community organizations. Fourth, it invites the development of new research methodologies appropriate for prevention studies, including improved designs and analytic strategies that can better capture complex prevention effects, real-world implementation variability, and longer-term outcomes.

This opportunity uses the NIH R01 mechanism, which is typically intended for substantial, hypothesis-driven projects with enough scope to produce definitive evidence. The announcement notes that it runs in parallel with two companion FOAs that share the same scientific scope but use smaller mechanisms: PA-08-218 for the R21 exploratory/developmental grant and PA-08-219 for the R03 small research grant. In practice, that means applicants should choose the mechanism that best matches the maturity and scale of their research plan, with PA-08-217 being the option for more comprehensive projects requiring larger budgets and longer timelines.

Funding levels and the number of awards are not fixed in advance. The FOA makes clear that award size and project duration will vary depending on the nature and scope of the proposed work, and that the total amount awarded and the number of funded projects will depend on the quantity and quality of applications received, as well as their requested costs and durations. There is no cost sharing or matching requirement, which reduces barriers for organizations that may not have discretionary resources to contribute to the project budget.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants span public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations (including small businesses), state and local governments (including counties, cities/townships, special districts, and independent school districts), public housing authorities/Indian housing authorities, and tribal governments and tribal organizations (both federally recognized and other than federally recognized). The FOA also explicitly includes a range of mission-driven and capacity-building institution types and community-linked entities, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and foreign (non-U.S.) organizations. This wide eligibility reflects the FOA's interest in prevention research that can be conducted in diverse settings and with populations that experience different patterns of risk, access, and service delivery.

Key administrative details from the source data include the Funding Opportunity Number PA-08-217, the CFDA number 93.279 (Drug Abuse and Addiction Research Programs), and an original posted date of July 28, 2008. The original and current closing date listed is September 7, 2011, and the archive date is October 8, 2011, indicating the announcement is no longer active but remains a useful reference point for the scope NIH sought under this line of prevention intervention research. The full announcement was hosted through the NIH grants guide, and the contact listed for access or technical issues is the NIH Office of Extramural Research (OER) Webmaster.

Frequently Asked Questions (FAQs) - Drug Abuse Prevention Intervention Research (R01) (PA-08-217)

What is PA-08-217?

PA-08-217 is a National Institutes of Health (NIH) discretionary funding opportunity titled Drug Abuse Prevention Intervention Research (R01). It supports full-scale Research Project Grant (R01) studies intended to strengthen and expand the science of preventing drug abuse and drug-related HIV.

What is the main purpose of this funding opportunity?

The purpose is to support prevention intervention research that moves beyond describing problems and generates actionable knowledge about how to prevent drug abuse and dependence and reduce related harms (including drug-related HIV and other infections) in ways that can translate to broader, population-level impact.

What outcomes and downstream harms does the FOA emphasize?

The FOA emphasizes reducing drug abuse and dependence and reducing harms that often accompany substance use, including drug-related HIV, other infections (such as hepatitis B and hepatitis C), co-occurring mental health problems, interpersonal violence, criminal justice involvement, and losses in work or school productivity.

What kind of research does this FOA encourage overall?

It encourages prevention intervention science that can realistically translate into real-world, broader impact, rather than remaining limited to small, highly controlled settings.

What are the four major types of research encouraged under this announcement?

The FOA highlights four major research types:

  • Development of novel prevention approaches (new strategies/programs/models to prevent initiation, escalation, or harmful consequences of drug use).
  • Testing of novel and adapted prevention intervention approaches (evaluating newly created interventions and rigorously examining interventions modified for new populations, cultures, delivery systems, or real-world constraints).
  • Implementation-oriented research (how evidence-based interventions are selected, adopted, adapted, implemented, sustained, and financed).
  • Development of new research methodologies (designs and analytic strategies suited to complex prevention effects, real-world implementation variability, and longer-term outcomes).

Does the FOA support only brand-new interventions?

No. In addition to developing novel approaches, the FOA also supports testing interventions that are adapted or modified for new populations, cultures, delivery systems, or real-world constraints, as long as the evaluation is rigorous.

What does the FOA mean by implementation-oriented research?

Implementation-oriented research focuses on what happens after an intervention exists: how it is selected and adopted, how it may be adapted, how it is implemented in real settings (schools, clinics, justice settings, social service systems, community organizations), how it is sustained over time, and how it is financed.

Why does the FOA emphasize feasibility, acceptability, and sustainability?

The announcement notes that even well-supported interventions can fail to make a difference if they are not feasible, affordable, acceptable to communities, or maintainable within the systems that would deliver them.

What grant mechanism does PA-08-217 use?

PA-08-217 uses the NIH R01 mechanism (Research Project Grant), which is typically intended for substantial, hypothesis-driven projects with enough scope to produce definitive evidence.

Are there companion funding opportunities with the same scientific scope?

Yes. The announcement runs in parallel with two companion FOAs with the same scientific scope but smaller grant mechanisms:

  • PA-08-218 for the R21 exploratory/developmental grant
  • PA-08-219 for the R03 small research grant

How should an applicant choose between the R01, R21, and R03 options mentioned?

Applicants should choose the mechanism that best matches the maturity and scale of their research plan. PA-08-217 (R01) is positioned for more comprehensive projects that require larger budgets and longer timelines than the companion R21 or R03 options.

Are the number of awards and funding levels predetermined?

No. The FOA states that funding levels and the number of awards are not fixed in advance. Award size and project duration will vary depending on the nature and scope of the proposed work, and totals will depend on the quantity and quality of applications received and the requested costs and durations.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

Who is eligible to apply?

Eligibility is broad and includes many types of U.S. and non-U.S. organizations, including:

  • Public and private institutions of higher education
  • Nonprofits with or without 501(c)(3) status
  • For-profit organizations (including small businesses)
  • State and local governments (including counties, cities/townships, special districts, and independent school districts)
  • Public housing authorities/Indian housing authorities
  • Tribal governments and tribal organizations (federally recognized and other than federally recognized)
  • U.S. territories or possessions
  • Foreign (non-U.S.) organizations

Does the FOA specifically mention institutions serving specific communities?

Yes. It explicitly includes institution types and community-linked entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations, among others.

Are foreign (non-U.S.) organizations eligible under this opportunity?

Yes. The FOA explicitly includes foreign (non-U.S.) organizations among eligible applicants.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.279, associated with Drug Abuse and Addiction Research Programs.

When was this opportunity posted, and is it still active?

The original posted date is July 28, 2008. The original and current closing date listed is September 7, 2011, and the archive date is October 8, 2011. Based on these dates, the announcement is no longer active and is preserved as an archived reference.

Where was the full announcement hosted?

The full announcement was hosted through the NIH grants guide.

Who is listed as the contact for access or technical issues?

The contact listed for access or technical issues is the NIH Office of Extramural Research (OER) Webmaster.

What is the Funding Opportunity Number for this FOA?

The Funding Opportunity Number is PA-08-217.

Browse more business programs for Drug Abuse Research and Prevention

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Drug Abuse Prevention Intervention Research (R21)

Previous opportunity: Deep Sequencing and Haplotype Profiling of Mental Disorders (Collaborative R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 217

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 217) also looked into and applied for these:

Funding Opportunity
Drug Abuse Prevention Intervention Research (R21) Apply for PA 08 218

Funding Number: PA 08 218
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Drug Abuse Prevention Intervention Research (R03) Apply for PA 08 219

Funding Number: PA 08 219
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Investigational Nutrigenetic Studies for Cancer Prevention (R01) Apply for PA 08 220

Funding Number: PA 08 220
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Investigational Nutrigenetic Studies for Cancer Prevention (R21) Apply for PA 08 221

Funding Number: PA 08 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21) Apply for PA 08 244

Funding Number: PA 08 244
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R03) Apply for RFA DA 09 019

Funding Number: RFA DA 09 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R01) Apply for RFA DA 09 017

Funding Number: RFA DA 09 017
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Physical Science Oncology Centers (U54) Apply for RFA CA 09 009

Funding Number: RFA CA 09 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,250,000
NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged Investigators (K01) Apply for PAR 05 135

Funding Number: PAR 05 135
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $20,000
NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 08 047

Funding Number: PAR 08 047
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR Career Transition Award (K22) Apply for PAR 08 148

Funding Number: PAR 08 148
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research on the Cognitive Sequelae of Parkinsons Disease (R01) Apply for PA 09 033

Funding Number: PA 09 033
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Established Investigator Award in Cancer Prevention and Control Apply for PAR 05 145

Funding Number: PAR 05 145
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Mentored Career Development Award to Promote Diversity (K01) Apply for PAR 06 220

Funding Number: PAR 06 220
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Mentored Clinical Scientist Award to Promote Diversity (K08) Apply for PAR 06 221

Funding Number: PAR 06 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mentored Patient Oriented Research Award to Promote Diversity (K23) Apply for PAR 06 222

Funding Number: PAR 06 222
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Building Translational Research in Integrative Behavioral Science (R24) Apply for PAR 06 357

Funding Number: PAR 06 357
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $225,000
Cancer Prevention, Control, Behavioral, and Population Sciences Career Development Award (K07) Apply for PAR 06 381

Funding Number: PAR 06 381
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $105,000
Paul Calabresi Career Development Award For Clinical Oncology (K12) Apply for PAR 06 449

Funding Number: PAR 06 449
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22) Apply for PAR 06 455

Funding Number: PAR 06 455
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 217", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.